Takeda Pharmaceutical reports decline in FY2020 revenue
Takeda meets FY2020 management guidance and records a 2.8% decline in reported revenue.
Market Data
Novo Nordisk reports increased Q1 2021 profit
Novo Nordisk has reported a net profit of kr12.6bn ($2.03bn) for the first quarter (Q1)...
Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success
According to the first-quarter results published by Pfizer this week, its coronavirus jab has reaped revenues of $3.5bn for the...
Pfizer’s Covid-19 vaccine sales boost revenue in Q1 2021
Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues...
Global rheumatologists’ biosimilar prescription rates shift from 2018 to 2020
The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market.
Over 50% of all chronic hepatitis B cases go undiagnosed in the 9MM
Chronic hepatitis B (CHB) is a viral liver disease that develops when the immune system cannot fight the hepatitis B virus and it remains in the body for six months…
NIH small business grant-funded drugs are being repurposed for Covid-19
Infectious disease therapies have been awarded the highest number of National Institutes of Health (NIH) grants over the last 20 years, according to GlobalData’s Pharmaceutical Intelligence Center’s deals database. The…
Twitter round-up: Eric Topol’s tweet on Covid-19 being transmitted through the air most popular tweet in Q1 2021
The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a…
Covid-19 was third cause of death in 2020, disrupting mortality trends and raising questions
The US Centers for Disease Control and Prevention (CDC) has revealed that Covid-19 was the third-highest cause of death in 2020. Covid-19 was also the main reason for the observed…
Lödige new LC light series for cost-efficient coating
Lödige Process Technology provides high-quality machines, systems and services, customised upon request, for process technology applications in the pharmaceutical industry. Earlier this year, Lödige Process Technology introduced a new series…
Sales forecast by class of drugs for hepatocellular carcinoma
Kinase inhibitors such as Bayer's Nexavar (sorafenib) and Eisai's Lenvima (lenvatinib), have dominated the hepatocellular carcinoma (HCC) market for more than a decade and until recently were the standard of…
